All India Institute of Ayurveda strengthens collaborations for insurance integration and research in Ayush sector

IMT News Desk
IMT News Desk
· 2 min read

The meeting focused on advancing insurance coverage and policy initiatives in the Ayush sector to ensure wider accessibility and integration of traditional medicine into mainstream healthcare

The Director of the All India Institute of Ayurveda (AIIA), Prof (Dr) Pradeep Kumar Prajapati, extended a warm welcome to Prof Bejon Kumar Misra, Chairman of the Core Group of Experts for Insurance, Ministry of Ayush. The meeting focused on advancing insurance coverage and policy initiatives in the Ayush sector to ensure wider accessibility and integration of traditional medicine into mainstream healthcare.

Recently, Union Minister of State for Ayush (Independent Charge) Prataprao Jadhav inaugurated the Project Management Unit (PMU) for Ayush Insurance–related matters at AIIA. During the discussion, Prof Prajapati emphasised that the PMU will provide a timely and transparent environment for stakeholders, facilitating effective implementation of insurance-related schemes. He assured that AIIA will play a pivotal role in ensuring easy access to information and the benefits of Ayush insurance schemes for the public.

On this occasion, Prof Prajapati also welcomed Dr Sanjay Srivastava, Vice Chancellor of Manav Rachna International Institute of Research and Studies (MRIIRS), Faridabad. The meeting with Dr Srivastava focused on exploring avenues for collaborative research and academic exchange to strengthen evidence-based practices in Ayurveda.

Prof (Dr) Pradeep Kumar Prajapati said, “AIIA is committed to fostering meaningful collaborations that bridge traditional wisdom with modern science. Strengthening research partnerships and policy frameworks such as insurance inclusion will significantly enhance the reach and credibility of the Ayush systems.”

These engagements highlight AIIA’s continued efforts to foster partnerships, promote policy innovations, and advance holistic health and wellness through the integration of traditional medicine and modern research approaches.

Read Next

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 
News
June 11, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 

DFE Pharma has earned its third consecutive Gold Medal from EcoVadis, the world leader in corporate sustainability assessments, in recognition of its strong performance in the four themes rated: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. This distinction places DFE Pharma in the top 5% of companies, reflecting the company’s focused efforts to […]
Article by: IMT News Desk
Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India
News
June 11, 2026

Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India

Oval Advanced Fertility Care and Merck Specialities Private Limited, the Indian healthcare arm of Merck KGaA, Darmstadt, Germany and a global leader in fertility sciences with decades of scientific leadership in reproductive medicine, have signed a strategic Memorandum of Understanding (MOU).   India’s IVF market, valued at approximately USD 2.35 billion in 2024, is projected […]
Article by: IMT News Desk
Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global
News
June 11, 2026

Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global

Bengaluru-based precision oncology startup 4baseCare has raised ₹128 crore in its ongoing Series B funding round to expand its hospital-linked genomics laboratory network globally and scale its AI-powered precision oncology platform, OncoTwin. The latest funding round, which follows a first close of ₹90 crore co-led by Ashish Kacholia and Lashit Sanghvi with participation from existing […]
Article by: IMT News Desk